Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Clinical trial NCT07301736 · RECRUITING
Trial details
- NCT number
- NCT07301736
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-17
- Primary completion
- 2027-06-03
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.